SCHEMBL25852146

SCHEMBL25852146

CCC1(CC)OC(C)(c2ccc3c(N)ccnn23)[C@H](OCc2ccccc2)[C@@H]1C

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ DHFR P00374 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25852224 0.87 TNK2 (0.33) DHFR
SCHEMBL17719233 0.77 — —
SCHEMBL26273792 0.77 — —
SCHEMBL25852191 0.75 DHFR (0.31) DHFR
SCHEMBL25852194 0.75 DHFR (0.31) DHFR
SCHEMBL25852255 0.74 TNK2 (0.35) —
SCHEMBL25852186 0.74 TNK2 (0.35) —
SCHEMBL17719234 0.74 — —
SCHEMBL17719358 0.74 — —
SCHEMBL10120857 0.69 TNK2 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11697666-B2 Methods of preparing carbanucleosides using amides GILEAD SCIENCES, INC. (US) 2023-07-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11697666-B2 Methods of preparing carbanucleosides using amides NCL, DUT, POLN DHFR 2359/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback